Short and Medium Term Results of Nitinol Self-Expending Stent (LifeStent) Implantation for Iliac Arteriosclerosis Obliteran_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 CHENBin , GAOPeng , YUJi-xiang , LIYu , MENGRan-ran , HUIFui-fui ,  YANGBin

Department of Vascular Surgery, The First People's Hospital of Jining City, Jining 272000, Shandong Province, China;

Corresponding author：

YANGBin, Email: 845243222@qq.com

Keywords：

Artery occlusive disease; Iliac artery; Self-expending stent; Angioplasty

DOI：

10.7507/1007-9424.20160157

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To evaluate short and medium term results of nitinol self-expending stent (LifeStent) implantation for iliac arteriosclerosis obliteran. Methods The clinical data of 75 limbs iliac artery occlusions in 64 patients from June 2011 to June 2014 in this hospital were analyzed retrospectively. The postoperative ankle brachial index (ABI), limb salvage rate, primary and secondary patency rate, and postoperative complications were evaluated. Results There were 75 limbs iliac artery occlusions in 64 patients (54 males and 10 females), 11 lesions were type A of TASCⅡ, 26 lesions were type B of TASCⅡ, 29 lesions were type C of TASCⅡ, 9 lesions were type D of TASCⅡ. The postoperative ABI was significantly higher than that preoperative ABI (0.94±0.16 versus 0.29±0.20, t=-24.7, P < 0.01). The following-up time was (22±10) months, 5 patients were lost to follow-up. In 12 and 24 months after surgery, the cumulative primary patency rates were 79% and 60%, respectively, the cumulative second patency rates were 91% and 84%, respectively, the limb salvage rates were 96% and 94%, respectively. Complications occurred in 5 patients (7.8%). There was no severe complications and inhospital mortality. Conclusion Clinical efficacy of short and medium term is satisfactory by nitinol self-expending stents implantation (LifeStent) for iliac arteriosclerosis obliteran, but long term efficacy remains to be further studied.

Citation： CHENBin, GAOPeng, YUJi-xiang, LIYu, MENGRan-ran, HUIFui-fui, YANGBin. Short and Medium Term Results of Nitinol Self-Expending Stent (LifeStent) Implantation for Iliac Arteriosclerosis Obliteran. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2016, 23(5): 586-589. doi: 10.7507/1007-9424.20160157 Copy

1.	Balzer JO, khan V, Thalhammer A, et al. Below the knee PTA in critical limb ischemia results after 12 months: single center experience. Eur J Radiol, 2010, 75(1): 31-42.
2.	Norgren L, Hiatt WR, Dormandy JA, et al. TASCⅡWorking Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol, 2007, 26(2): 81-157.
3.	Baril DT, Chaer RA, Rhee RY, et al. Endovascular interventions for TASCⅡD femoropopliteal lesions. J Vasc Surg, 2010, 51(6): 1406-1412.
4.	邢彤, 杨宝钟, 宋盛晗, 等.腔内支架植入治疗TASCⅡC、D型股腘动脉慢性闭塞病变.中华普通外科杂志, 2012, 27(8): 616-618.
5.	kim SJ, kim W, kim JB, et al. Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease. Cire J, 2010, 74(9): 1959-1964.
6.	叶炜, 刘昌伟, 李拥军, 等.老年人下肢动脉硬化闭塞症腔内治疗效果分析.中华外科杂志, 2010, 48(4): 261-264.
7.	朱雅亭, 郭伟.周围动脉支架内再狭窄的处理.中华医学杂志, 2012, 92(19), 1363-1364.
8.	温志国, 杜丽苹, 李小华, 等. TASC C D型下肢动脉硬化闭塞症的腔内治疗.中华普通外科杂志, 2014, 29(1): 29-31.
9.	吴庆华, 杨培.论TASC分型与下肢动脉硬化闭塞的治疗选择.中华普通外科杂志, 2009, 24(6): 433-435.
10.	The task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). ESC guidelines on the diagnosis and treatment of peripheral artery diseases. http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx.
11.	黄斌, 陈熹阳, 赵纪春, 等.外科结合腔内治疗下肢动脉硬化闭塞症.中国普外基础与临床, 2015, 22(8): 926-928.
12.	陈忠, 王盛, 唐小斌, 等.主髂动脉硬化闭塞症的腔内治疗.心肺血管病杂志, 2010, 29(6): 446-448.
13.	黄俊杰, 张秀军, 张晶.导管直接溶栓联合动脉成形术治疗慢性股浅动脉闭塞症.中华普外科杂志, 2014, 29(9): 704-707.
14.	吴田方, 代远斌.不同材料周围动脉支架置入治疗动脉硬化闭塞症的研究与进展.中国组织工程研究, 2012, 16(12): 2261-2264.
15.	Iida O, Nanto S, Uematsu M, et al. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4years. JACC Cardiovasc Interv, 2009, 2(7): 665-671.
16.	George JC, Rosen ES, Nachtigall J, et al. SUPERA interwoven nitinolStent Outcomes in Above-knee IntErventions (SAkE) study. J Vasc Interv Radiol, 2014, 25(6): 954-961.
17.	Lejay A, Thaveau F, Girsowicz E, et al. Stent evolution for peripheral arterial disease. J Cardiovasc Surg (Torino), 2012, 53(1 Suppl 1): 171-179.
18.	杨心蕊, 陆信武, 叶开创, 等.自膨式裸支架治疗股腘动脉狭窄闭塞性病变的临床评价.中华普通外科杂志, 2014, 29(8): 600-602.
19.	Adlakha S, Sheikh M, Wu J, et al. Stent fracture in the coronary and peripheral arteries. J Interv Cardiol, 2010, 23(4): 411-419.
20.	Farzan G, Niju BN, Anatoliy T, et al. Use of Viabahn stent for the treatment of in-stent restenosis in the superficial femoral artery.Cardiovasc Revasc Med, 2012, 13: e3-e19.
21.	田硕, 黄新天, 殷敏毅, 等.下肢动脉粥样硬化闭塞症腔内治疗后再闭塞的原因分析及应对策略.中国血管外科杂志:电子版, 2013, 5(2): 83-85.
22.	Bernstein O, Chalmers N. New treatments for infrapopliteal disease:devices, techniques, and outcomes so far. Cardiovasc Intervent Radiol, 2012, 35(4): 715-724.
23.	陈彬, 刘军军, 赵宗刚, 等.不同自膨式金属支架混合置入治疗股腘动脉硬化闭塞:生物相容性及保肢率.中国组织工程研究, 2015, 19(8): 1233-1238.

1. Balzer JO, khan V, Thalhammer A, et al. Below the knee PTA in critical limb ischemia results after 12 months: single center experience. Eur J Radiol, 2010, 75(1): 31-42.
2. Norgren L, Hiatt WR, Dormandy JA, et al. TASCⅡWorking Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol, 2007, 26(2): 81-157.
3. Baril DT, Chaer RA, Rhee RY, et al. Endovascular interventions for TASCⅡD femoropopliteal lesions. J Vasc Surg, 2010, 51(6): 1406-1412.
4. 邢彤, 杨宝钟, 宋盛晗, 等.腔内支架植入治疗TASCⅡC、D型股腘动脉慢性闭塞病变.中华普通外科杂志, 2012, 27(8): 616-618.
5. kim SJ, kim W, kim JB, et al. Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease. Cire J, 2010, 74(9): 1959-1964.
6. 叶炜, 刘昌伟, 李拥军, 等.老年人下肢动脉硬化闭塞症腔内治疗效果分析.中华外科杂志, 2010, 48(4): 261-264.
7. 朱雅亭, 郭伟.周围动脉支架内再狭窄的处理.中华医学杂志, 2012, 92(19), 1363-1364.
8. 温志国, 杜丽苹, 李小华, 等. TASC C D型下肢动脉硬化闭塞症的腔内治疗.中华普通外科杂志, 2014, 29(1): 29-31.
9. 吴庆华, 杨培.论TASC分型与下肢动脉硬化闭塞的治疗选择.中华普通外科杂志, 2009, 24(6): 433-435.
10. The task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). ESC guidelines on the diagnosis and treatment of peripheral artery diseases. http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx.
11. 黄斌, 陈熹阳, 赵纪春, 等.外科结合腔内治疗下肢动脉硬化闭塞症.中国普外基础与临床, 2015, 22(8): 926-928.
12. 陈忠, 王盛, 唐小斌, 等.主髂动脉硬化闭塞症的腔内治疗.心肺血管病杂志, 2010, 29(6): 446-448.
13. 黄俊杰, 张秀军, 张晶.导管直接溶栓联合动脉成形术治疗慢性股浅动脉闭塞症.中华普外科杂志, 2014, 29(9): 704-707.
14. 吴田方, 代远斌.不同材料周围动脉支架置入治疗动脉硬化闭塞症的研究与进展.中国组织工程研究, 2012, 16(12): 2261-2264.
15. Iida O, Nanto S, Uematsu M, et al. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4years. JACC Cardiovasc Interv, 2009, 2(7): 665-671.
16. George JC, Rosen ES, Nachtigall J, et al. SUPERA interwoven nitinolStent Outcomes in Above-knee IntErventions (SAkE) study. J Vasc Interv Radiol, 2014, 25(6): 954-961.
17. Lejay A, Thaveau F, Girsowicz E, et al. Stent evolution for peripheral arterial disease. J Cardiovasc Surg (Torino), 2012, 53(1 Suppl 1): 171-179.
18. 杨心蕊, 陆信武, 叶开创, 等.自膨式裸支架治疗股腘动脉狭窄闭塞性病变的临床评价.中华普通外科杂志, 2014, 29(8): 600-602.
19. Adlakha S, Sheikh M, Wu J, et al. Stent fracture in the coronary and peripheral arteries. J Interv Cardiol, 2010, 23(4): 411-419.
20. Farzan G, Niju BN, Anatoliy T, et al. Use of Viabahn stent for the treatment of in-stent restenosis in the superficial femoral artery.Cardiovasc Revasc Med, 2012, 13: e3-e19.
21. 田硕, 黄新天, 殷敏毅, 等.下肢动脉粥样硬化闭塞症腔内治疗后再闭塞的原因分析及应对策略.中国血管外科杂志:电子版, 2013, 5(2): 83-85.
22. Bernstein O, Chalmers N. New treatments for infrapopliteal disease:devices, techniques, and outcomes so far. Cardiovasc Intervent Radiol, 2012, 35(4): 715-724.
23. 陈彬, 刘军军, 赵宗刚, 等.不同自膨式金属支架混合置入治疗股腘动脉硬化闭塞:生物相容性及保肢率.中国组织工程研究, 2015, 19(8): 1233-1238.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Short and Medium Term Results of Nitinol Self-Expending Stent (LifeStent) Implantation for Iliac Arteriosclerosis Obliteran

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content